Desjardins Issues Pessimistic Forecast for Extendicare (TSE:EXE) Stock Price

Extendicare (TSE:EXEGet Free Report) had its target price reduced by research analysts at Desjardins from C$40.00 to C$39.00 in a report released on Monday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Desjardins’ target price suggests a potential upside of 21.16% from the stock’s previous close.

EXE has been the topic of a number of other research reports. BMO Capital Markets increased their price objective on shares of Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. TD boosted their target price on shares of Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Canaccord Genuity Group upgraded shares of Extendicare to a “strong-buy” rating in a research report on Monday, May 11th. Finally, National Bank Financial increased their price target on shares of Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$35.44.

View Our Latest Report on EXE

Extendicare Price Performance

EXE stock traded down C$0.25 during trading on Monday, hitting C$32.19. 363,614 shares of the stock traded hands, compared to its average volume of 388,127. Extendicare has a one year low of C$12.64 and a one year high of C$39.14. The stock has a market cap of C$3.05 billion, a price-to-earnings ratio of 23.69 and a beta of 1.59. The company has a 50 day simple moving average of C$35.24 and a 200 day simple moving average of C$30.25. The company has a current ratio of 1.44, a quick ratio of 0.98 and a debt-to-equity ratio of 82.55.

Extendicare (TSE:EXEGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported C$0.32 earnings per share for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The firm had revenue of C$611.04 million for the quarter. Equities analysts expect that Extendicare will post 0.6134729 EPS for the current fiscal year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.